Corporate Overview Statutory Reports Financial Statements 177 Note 29.12 Leases a) As a lessee The Company has taken various residential and office premises under operating lease or leave and license agreements. These are cancellable by the Company, having a term between 11 months and three years and have no specific obligation for real. Payments are recognised in the Standalone Statement of Profit and Loss under ‘Rent’ in Note 28. b) As a lessor i) Operating lease T he Company has entered into operating leases on its office Buildings and land. These are cancellable by the Company, having a term between 11 months and three years and have no specific obligation for real. Rents received are recognised in the Standalone Statement of Profit and Loss as lease income in Note 22 ‘Other income’. ii) Finance lease The Company has given a Building on finance lease for a term of 30 years and a machine for a term of 10 years. F uture minimum lease payments receivable under finance leases, together with the present value of the net minimum lease payments (MLP), are as under: (` cr) Particulars As at March 31, 2024 As at March 31, 2023 MLP receivable Present value of MLP receivable MLP receivable Present value of MLP receivable Not later than one year 1.82 1.73 2.02 1.93 Later than one year and not later than five years 7.69 5.91 7.69 5.88 Later than five years 5.63 3.23 7.44 4.07 Total MLP receivable 15.14 10.87 17.15 11.89 Less: unearned finance income 4.27 - 5.26 - Present value of MLP receivable 10.87 10.87 11.89 11.89 Less: allowance for uncollectible lease payments - - - - 10.87 10.87 11.89 11.89 Note 29.13 Loans, investments and guarantees Disclosures pursuant to the Regulation 34(3) read with para A of Schedule V to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Section 186 (4) of the Companies Act, 2013. a) Loans (` cr) Particulars Maturity Interest rate p.a. Purpose Amount outstanding as at Maximum balance during the year March 31, 2024 March 31, 2023 2023-24 2022-23 i) Subsidiary companies: Atul Bioscience Ltd June 2025 8.80% For working capital, operational, project expenditure requirement and purchase of the manufacturing facility at Ambernath 12.53 54.55 54.55 58.56 Atul Finserv Ltd August 2024 9.05% Providing financial support to Anaven project 25.00 - 25.00 - Atul Products Ltd - - For project expenditure requirement - 760.45 769.95 760.45 Atul Rajasthan Date Palms Ltd February 2027 11.65% For working capital 4.00 4.00 4.00 4.00 ii) Joint operation of subsidiary company: Anaven LLP March 2026 9.75% to 10.85% For working capital, operational and project expenditure requirement 30.72 53.98 53.98 70.75 Notes: a) Loans given to employees as per the policy of the Company are not considered. b) The loanees did not hold any shares in the share capital of the Company. b) Details of investments made and guarantees provided are given in Note 5.1 and Note 29.1(b), respectively.
RkJQdWJsaXNoZXIy MjA2MDI2